Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
PHARMAC · 7 medicines
Show all 7HSA · 5 medicines
Anvisa · 3 medicines
AEMPS · 3 medicines
SFDA · 3 medicines · Historical list
TFDA · 2 medicines · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
30 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Hydralazine Hydrochloride | United States | 20MG/ML | injectable | Marketed | Smith and Nephew |
| Hydralazine Hydrochloride | United States | 100MG, 10MG, 25MG … | tablet | Marketed | Upsher Smith Labs |
| Hydralazine and HydrochlorothiazideCombination | United States | 25MG; 15MG | tablet | Not marketed | Watson Labs |
| Hydralazine Hydrochloride and HydrochlorothiazideCombination | United States | 100MG; 50MG, 25MG; 25MG, 50MG; 50MG | capsule | Not marketed | Solvay |
| Hydralazine Hydrochloride W/ Hydrochlorothiazide 25/25Combination | United States | 25MG; 25MG | capsule | Not marketed | Ivax Pharms |
| Hydralazine Hydrochloride W/ Hydrochlorothiazide 50/50Combination | United States | 50MG; 50MG | capsule | Not marketed | Ivax Pharms |
| Hydralazine Hydrochloride-Hydrochlorothiazide-ReserpineCombination | United States | 25MG; 15MG; 0.1MG | tablet | Not marketed | Mylan |
| Hydralazine, Hydrochlorothiazide W/ ReserpineCombination | United States | 25MG; 15MG; 0.1MG | tablet | Not marketed | Watson Labs |
| Hydralazine Hydrochloride W/ Hydrochlorothiazide 100/50Combination | United States | 100MG; 50MG | capsule | Not marketed | Ivax Pharms |
| Hydralazine Hydrochloride, Hydrochlorothiazide and ReserpineCombination | United States | 25MG; 15MG; 0.1MG | tablet | Not marketed | Ivax Sub Teva Pharms |
| Isosorbide Dinitrate and Hydralazine HydrochlorideCombination | United States | 37.5MG; 20MG | tablet | Marketed | Ingenus Pharms LLC |
| Hydrochlorothiazide W/ HydralazineCombination | United States | 25MG; 15MG | tablet | Not marketed | Watson Labs |
| Dralzine | United States | 25MG | tablet | Not marketed | Teva |
| Hydrap-EsCombination | United States | 25MG; 15MG; 0.1MG | tablet | Not marketed | Sandoz |
| Hydrochlorothiazide W/ Reserpine and HydralazineCombination | United States | 25MG; 15MG; 0.1MG | tablet | Not marketed | Watson Labs |
| Reserpine, Hydralazine Hydrochloride and HydrochlorothiazideCombination | United States | 25MG; 15MG; 0.1MG | tablet | Not marketed | Solvay |
| Reserpine, Hydrochlorothiazide, and Hydralazine HydrochlorideCombination | United States | 25MG; 15MG; 0.1MG | tablet | Not marketed | Lederle |
| Hydra-ZideCombination | United States | 100MG; 50MG, 25MG; 25MG, 50MG; 50MG | capsule | Not marketed | Strides Pharma Intl |
| BidilCombination | United States | 37.5MG; 20MG | tablet | Marketed | Azurity |
| Hydroserpine Plus (R-H-H)Combination | United States | 25MG; 15MG; 0.1MG | tablet | Not marketed | Ivax Sub Teva Pharms |
| DralserpCombination | United States | 25MG; 0.1MG | tablet | Not marketed | Sandoz |
| Apresoline | United States | 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Not marketed | Novartis |
| Apresoline | United States | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Not marketed | Novartis |
| Apresoline-EsidrixCombination | United States | 25MG; 15MG | tablet | Not marketed | Novartis |
| Serpasil-ApresolineCombination | United States | 25MG; 0.1MG, 50MG; 0.2MG | tablet | Not marketed | Novartis |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, Anvisa, FDA, Health Canada, HSA, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
